BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Metabolism of nitric oxide
,
Rosiglitazone
,
rs6983267
,
BRCA1
,
Allergy to pollen
,
Lung
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Tafamidis
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
Explore Curated Studies Results
Literature
Most Relevant Literature
Tafamidis concentration required for transthyretin stabilisation in cerebrospinal fluid.
Changes in Exercise Tolerance over Time in Patients with Transthyretin Amyloidosis Cardiomyopathy Tr…
Impact of Tafamidis on Echocardiographic Cardiac Function of Patients With Transthyretin Cardiac Amy…
Real-World Efficacy of Tafamidis in Patients With Transthyretin Amyloidosis and Heart Failure.
Long-term survival in people with transthyretin amyloid cardiomyopathy who took tafamidis: A Plain L…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
The Effect Of Tafamidis Meglumine In Transthyretin Amyloid Polyneuropathy Patients
Safety, Efficacy, and Pharmacokinetics of Tafamidis in Patients With Transthyretin-mediated Amyloido…
Long-term Safety of Tafamidis in Subjects With Transthyretin Cardiomyopathy
Safety And Pharmacokinetic Assessment Of Orally Administered Tafamidis In Healthy Volunteers
A Study to Determine the Bioequivalence of Two Doses of Tafamidis
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ